Skip to main content

Find Clinical Trials

Clinical trial condition

HIV-1

Explore clinical trials studying HIV-1. Study availability and eligibility vary by location and protocol.

66 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

HIV-1 trial results

Completed

A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

NCT02217904

Conditions: HIV-1
Locations: Not specified

View Trial Details

Completed

Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients

NCT03279835

Conditions: HIV-1
Locations: Hôpital Pasteur 2 - Service de Neurologie Nice, France

View Trial Details

Completed

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

NCT02993237

Conditions: HIV-1
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Emory University Atlanta, Georgia, United States

St Jude Children's Research Hospital Memphis, Tennessee, United States

University of Texas Health Science Center Houston, Texas, United States

View Trial Details

Completed

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

NCT01177059

Conditions: HIV-1
Locations: Los Angeles, California, United States

San Francisco, California, United States

New York, United States

Darlinghurst, Australia

View Trial Details

Completed

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Pueblo Family Physicians, Ltd. Phoenix, Arizona, United States

Pacific Oaks Medical Group Beverly Hills, California, United States

Kaiser Permanente Hayward, California, United States

Long Beach Education and Research Consultants Long Beach, California, United States

View all 62 locations

View Trial Details

Completed

Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial

NCT00337181

Conditions: HIV-1
Locations: Chon Buri Regional Hospital Chon Buri, Chon Buri Province, Thailand

View Trial Details

Completed

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

NCT02513147

Conditions: HIV-1
Locations: Hospital Universitari Vall d'Hebron Barcelona, Spain

View Trial Details

Completed

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

NCT02547844

Conditions: HIV-1
Locations: Hospital Universitari Vall d'Hebron Barcelona, Spain

View Trial Details

Completed

Treatment De-Intensification and Residual HIV-1 in Youth

NCT00867854

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Children's Hospital of Los Angeles Los Angeles, California, United States

University of California at San Francisco San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Howard University - IMPAACT Site Washington D.C., District of Columbia, United States

View all 17 locations

View Trial Details

Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

NCT00074997

Conditions: HIV-1
Locations: Darlinghurst, Australia

View Trial Details